EQUITY ALERT: Rosen Law Firm Announces Investigation of Securities Claims Against Fresenius Medical Care AG
& Co. KGAA - FMS
Rosen Law Firm, a global investor rights law firm, announces it is investigating potential securities claims on behalf of
shareholders of Fresenius Medical Care AG & Co. KGAA (NYSE: FMS) resulting from allegations that Fresenius may have issued
materially misleading business information to the investing public.
On January 6, 2017, after the close of trading, the Wall Street Journal published an article revealing that Fresenius’s
U.S. unit had received subpoenas from federal prosecutors seeking information on Fresenius’s ties with the American Kidney Fund, a
charity that helps patients pay for kidney dialysis. On this news, shares of Fresenius have fallen approximately 7% during intraday
trading on January 9, 2017.
Rosen Law Firm is preparing a class action lawsuit to recover losses suffered by Fresenius investors. If you purchased shares of
Fresenius before January 9, 2017 please visit the firm’s website at http://www.rosenlegal.com/cases-1027.html for more information. You may also contact Phillip Kim or Kevin Chan
of Rosen Law Firm toll free at 866-767-3653 or via email at pkim@rosenlegal.com or kchan@rosenlegal.com.
Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm or on Twitter: https://twitter.com/rosen_firm.
Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder
derivative litigation.
Attorney Advertising. Prior results do not guarantee a similar outcome.
The Rosen Law Firm, P.A.
Laurence Rosen, Esq.
Phillip Kim, Esq.
Kevin Chan, Esq.
275 Madison Avenue, 34th Floor
New York, NY 10016
Tel: 212-686-1060
Toll Free: 866-767-3653
Fax: 212-202-3827
lrosen@rosenlegal.com
pkim@rosenlegal.com
kchan@rosenlegal.com
www.rosenlegal.com
View source version on businesswire.com: http://www.businesswire.com/news/home/20170109006351/en/